Surmounting Recalcitrant Airway Inflammatory Disorders With a Multi‐Targeting Therapeutic Strategy by Tannic Acid‐Modified CuInP 2 S 6 Nanosheets
Authors:
Open Access
- 12 March 2026
- journal article
- Published by Wiley in Exploration
- Vol. 6 (2)
Abstract
Recalcitrant airway inflammatory diseases have drawn significant attention due to their high incidence and substantial healthcare costs. Analysis of clinical samples from patients with chronic rhinosinusitis with nasal polyps (CRSwNP) revealed the coexistence of neutrophilic and eosinophilic inflammation, which may account for the limited efficacy of traditional single‐target therapeutic strategies. Moreover, cell‐free DNA (cfDNA)—an emerging inflammatory mediator—has been implicated in both eosinophilic and neutrophilic responses through its role in the formation of extracellular traps. In this study, we developed tannic acid (TA)‐modified CuInP 2 S 6 (CIPS) nanosheets (C‐TA 1 ; w/w = 1:1) as a multi‐targeting therapeutic nanoplatform for recalcitrant airway inflammatory diseases. The C‐TA 1 nanosheets demonstrated efficient cfDNA clearance via hydrogen bonding interactions, thereby inhibiting cfDNA‐triggered toll‐like receptor 9 (TLR9) activation and subsequent nuclear factor‐κB (NF‐κB) inflammatory signaling. Additionally, C‐TA 1 exhibited potent antioxidant and antibacterial activities, which were ascribed to the inherent properties of the two‐dimensional nanostructure and the chemical characteristics of TA, respectively. The in vivo therapeutic efficacy of C‐TA 1 was evaluated in murine models with neutrophilic and eosinophilic airway inflammation, respectively. C‐TA 1 markedly attenuated airway inflammation in both of these animal models by reducing reactive species, immune cell infiltration, goblet cell hyperplasia and the expression of pro‑inflammatory cytokines. Furthermore, treatment with C‐TA 1 effectively modulated the dysregulated airway microbiota observed in the inflammatory state. Our findings demonstrate a multi‐targeting nanoformulation designed to mitigate multiple key pathological drivers of severe airway inflammation concurrently. This engineered system presents a promising strategy for managing respiratory inflammatory disorders and also other inflammation‐related diseases.Keywords
Funding Information
- National Natural Science Foundation of China (82271188)
- Natural Science Foundation of Guangdong Province (2023B1111040004)
This publication has 67 references indexed in Scilit:
- Nanocapsuled Neutrophil Extracellular Trap Scavenger Combating Chronic Infectious Bone Destruction DiseasesAdvanced Science, 2025
- Functional 2D Nanoplatforms Alleviate Eosinophilic Chronic Rhinosinusitis by Modulating Eosinophil Extracellular Trap FormationAdvanced Science, 2024
- An ROS‐Scavenging Treg‐Recruiting Hydrogel Patch for Diabetic Wound HealingAdvanced Functional Materials, 2024
- Multifunctional Cationic Hyperbranched Polyaminoglycosides that Target Multiple Mediators for Severe Abdominal Trauma ManagementAdvanced Science, 2023
- Construction of CpG Delivery Nanoplatforms by Functionalized MoS2 Nanosheets for Boosting Antitumor Immunity in Head and Neck Squamous Cell CarcinomaSmall, 2023
- Polyglycerol‐Amine Covered Nanosheets Target Cell‐Free DNA to Attenuate Acute Kidney InjuryAdvanced Science, 2023
- Recent advances in targeted antibacterial therapy basing on nanomaterialsExploration, 2023
- Engineering metal‐phenolic networks for enhancing cancer therapy by tumor microenvironment modulationWIREs Nanomedicine and Nanobiotechnology, 2022
- Recent applications of immunomodulatory biomaterials for disease immunotherapyExploration, 2022
- DNA/Tannic Acid Hybrid Gel Exhibiting Biodegradability, Extensibility, Tissue Adhesiveness, and Hemostatic AbilityAdvanced Functional Materials, 2015